Literature DB >> 20675587

B1 cells promote pancreas infiltration by autoreactive T cells.

Gemma A Ryan1, Chun Jing Wang, Jayne L Chamberlain, Kesley Attridge, Emily M Schmidt, Rupert Kenefeck, Louise E Clough, Kyri Dunussi-Joannopoulos, Kai-Michael Toellner, Lucy S K Walker.   

Abstract

The entry of autoreactive T cells into the pancreas is a critical checkpoint in the development of autoimmune diabetes. In this study, we identify a role for B1 cells in this process using the DO11 x RIP-mOVA mouse model. In transgenic mice with islet-specific T cells, but no B cells, T cells are primed in the pancreatic lymph node but fail to enter the pancreas. Reconstitution of the B1 cell population by adoptive transfer permits extensive T cell pancreas infiltration. Reconstituted B1 cells traffic to the pancreas and modify expression of adhesion molecules on pancreatic vasculature, notably VCAM-1. Despite substantial pancreas infiltration, islet destruction is minimal unless regulatory T cells are depleted. These data identify a role for B1 cells in permitting circulating islet-specific T cells to access their Ag-bearing tissue and emphasize the existence of multiple checkpoints to regulate autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675587      PMCID: PMC3983558          DOI: 10.4049/jimmunol.1000856

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice.

Authors:  S A Greeley; D J Moore; H Noorchashm; L E Noto; S Y Rostami; A Schlachterman; H K Song; B Koeberlein; C F Barker; A Naji
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

2.  B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice.

Authors:  H Noorchashm; N Noorchashm; J Kern; S Y Rostami; C F Barker; A Naji
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

3.  Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.

Authors:  Shabbir Hussain; Terry L Delovitch
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

4.  Pre-diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells.

Authors:  B M Dean; R Walker; A J Bone; J D Baird; A Cooke
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

5.  B cells regulate autoimmunity by provision of IL-10.

Authors:  Simon Fillatreau; Claire H Sweenie; Mandy J McGeachy; David Gray; Stephen M Anderton
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

6.  Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.

Authors:  Mark D Pescovitz; Carla J Greenbaum; Heidi Krause-Steinrauf; Dorothy J Becker; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Jennifer B Marks; Paula F McGee; Antoinette M Moran; Philip Raskin; Henry Rodriguez; Desmond A Schatz; Diane Wherrett; Darrell M Wilson; John M Lachin; Jay S Skyler
Journal:  N Engl J Med       Date:  2009-11-26       Impact factor: 91.245

7.  B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.

Authors:  D V Serreze; S A Fleming; H D Chapman; S D Richard; E H Leiter; R M Tisch
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

8.  Analysis of islet inflammation in human type 1 diabetes.

Authors:  A Willcox; S J Richardson; A J Bone; A K Foulis; N G Morgan
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

Review 9.  Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

Authors:  I André; A Gonzalez; B Wang; J Katz; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.

Authors:  Paolo Fiorina; Andrea Vergani; Shirine Dada; Mollie Jurewicz; Masie Wong; Kenneth Law; Erxi Wu; Ze Tian; Reza Abdi; Indira Guleria; Scott Rodig; Kyri Dunussi-Joannopoulos; Jeffrey Bluestone; Mohamed H Sayegh
Journal:  Diabetes       Date:  2008-08-08       Impact factor: 9.461

View more
  17 in total

Review 1.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 2.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

3.  Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes.

Authors:  Jan Czyzyk; Octavian Henegariu; Paula Preston-Hurlburt; Raman Baldzizhar; Christine Fedorchuk; Enric Esplugues; Kim Bottomly; Frans K Gorus; Kevan Herold; Richard A Flavell
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

Review 4.  Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.

Authors:  Maran L Sprouse; Nicholas A Bates; Krysta M Felix; Hsin-Jung Joyce Wu
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

5.  Innate stimulation of B1a cells enhances the autoreactive IgM repertoire in the NOD mouse: implications for type 1 diabetes.

Authors:  J Côrte-Real; N Duarte; L Tavares; C Penha-Gonçalves
Journal:  Diabetologia       Date:  2012-03-01       Impact factor: 10.122

6.  In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis.

Authors:  Nahir Garabatos; Raimon Alvarez; Jorge Carrillo; Jorge Carrascal; Cristina Izquierdo; Harold D Chapman; Maximiliano Presa; Conchi Mora; David V Serreze; Joan Verdaguer; Thomas Stratmann
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

7.  Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice.

Authors:  C Alam; E Bittoun; D Bhagwat; S Valkonen; A Saari; U Jaakkola; E Eerola; P Huovinen; A Hänninen
Journal:  Diabetologia       Date:  2011-03-05       Impact factor: 10.122

8.  Human-derived natural antibodies: biomarkers and potential therapeutics.

Authors:  Xiaohua Xu; Sher May Ng; Eamonn Hassouna; Arthur Warrington; Sang-Hyun Oh; Moses Rodriguez
Journal:  Future Neurol       Date:  2015

Review 9.  B cell depletion in autoimmune diabetes: insights from murine models.

Authors:  Jayne L Chamberlain; Kesley Attridge; Chun Jing Wang; Gemma A Ryan; Lucy Sk Walker
Journal:  Expert Opin Ther Targets       Date:  2011-03-03       Impact factor: 6.902

10.  Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes.

Authors:  V Di Caro; B Phillips; C Engman; J Harnaha; M Trucco; N Giannoukakis
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.